Skip to content

EQUISOCK: New Antiequine

EQUISOCK: New Antiequine for Ankle

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07333768
Acronym
EQUISOCK
Enrollment
4
Registered
2026-01-12
Start date
2026-07-01
Completion date
2026-12-31
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Dorsiflexion, Ankle Equinus, Ankle (Ligaments); Instability (Old Injury)

Brief summary

The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with ankle lesions (external popliteal sciatic nerve or nerve injuries resulting in loss of ankle dorsiflexion) of both sexes and all ages. The main question it aims to answer is:Is the new orthosis a support for ankle stability??Does the new orthosis improve ankle function and patients' quality of life??The control group will be the subjects themselves when wearing their conventional ankle orthosis or without it. Participants must wear the new ankle orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the ankle joint and muscles.

Interventions

DEVICEEQUISOCK

Participants must wear the new ankle orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.

DEVICEOther ankle orthosis

Participants must wear the conventional ankle orthosis and without orthosis, during assessments and before wearing the new one

Sponsors

University of Salamanca
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with chronic ankle injuries * patients with external popliteal sciatic nerve lesion or nerve injuries resulting in loss of ankle dorsiflexion * patients who have already been prescribed an orthosis * patients of all ages

Exclusion criteria

* inability to stand actively and stably * inability to walk unaided * inability to follow instructions

Design outcomes

Primary

MeasureTime frameDescription
Device FeasibilityBaseline and up to 4 weeksDevice feasibility will be assessed through participants' awareness of the device, as an indicator of its accessibility, visibility, and potential for effective implementation within the target population. A self diary Will be requested

Secondary

MeasureTime frameDescription
Ankle function with virtual realityBaseline and up to 4 weeksAnkle function will be assessed using a virtual reality programme that requires movement of the lower limb to assess ankle stability, with and without orthosis. The assessment will be using a Borg scale (range of effort that the individual perceives when exercising). From 0 points (minimum effort) to 10 points (maximum effort).
Range of motion with Gyko deviceBaseline and up to 4 weeksThe range of motion of the knee joint will be measured using the Gyko device with and without the new orthosis. The assessment will be in degrees (from 0 to 120º)
Footprint with a pressure platformBaseline and up to 4 weeksThe distribution of static and dynamic load will be assessed with and without orthosis, using a pressure platform, as well as static balance with eyes open and closed and dynamic balance. The assessment will be the percentage of support from the sole of the foot in each movement.

Countries

Spain

Contacts

CONTACTRocio Llamas-Ramos Dr.
rociollamas@usal.es+34657854188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026